Regulator has link to firm implicated in meningitis outbreak
The owners of New England Compounding Center, the Framingham company at the heart of a nationwide outbreak of fungal meningitis, also own a related pharmacy in Westborough, one of whose executives is a board member and former president of the state agency that regulates pharmacies. Sophia Pasedis was appointed to the 11-member Massachusetts Board of Registration in Pharmacy in June 2004 and was reappointed in 2008. She is vice president of regulatory affairs and compliance at Ameridose, according to the company's website. State health officials have said New England Compounding was licensed only to dispense and mix medications for individual patients, raising questions about how and why it was allowed to ship thousands of vials of the drugs to facilities nationwide.
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- Quiet ORs Better for Patient Safety
- Tavenner Confirmed as CMS Administrator
- Leapfrog Hospital Safety Scores 'Depressing'
- Building a Better Healthcare Board
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Hard-Nosed About Physician Teamwork
- Healthcare Leaders Sound Off on Organized Labor
- Rural Healthcare Can Entice the Best and Brightest
- How Medical Debt Forgiveness Benefits Hospitals
